Article
Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI.
PloS one - 1 Jan 2013
Park Kyung Woo, Park Jin Joo, Kang Jeehoon, Jeon Ki-Hyun, Kang Si-Hyuck, Han Jung-Kyu, Lee Sang Eun, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-Soo
Abstract excerpt
BACKGROUND: Paraoxonase (PON) is a high-density-lipoprotein (HDL) associated enzyme with antioxidative and anti-atherogenic property. Its function is associated with coronary artery disease and its activity genetically controlled. We evaluated whether genetic variation of PON-1 is associated with clinical outcome in a large cohort of Korean patients with drug-eluting stents implantation. METHODS: A total of 1676...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
